Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: Revolution Medicines Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Revolution Medicines Inc. June 26, 202585.5%
-
Replimune Group Inc. September 4, 202499.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 10, 2026 | Replimune Group Inc. | Open-market sale | −39,341 | $12.97 | $510,253 |
| Jun 29, 2026 | Revolution Medicines Inc. | Option exercise | +2,955 | $37.54 | $110,931 |
| Jun 29, 2026 | Revolution Medicines Inc. | Open-market sale | −300 | $183.17 | $54,951 |
| Jun 29, 2026 | Revolution Medicines Inc. | Open-market sale | −900 | $184.59 | $166,131 |
| Jun 29, 2026 | Revolution Medicines Inc. | Open-market sale | −1,100 | $185.90 | $204,490 |
| Jun 29, 2026 | Revolution Medicines Inc. | Open-market sale | −858 | $186.92 | $160,377 |
| Jun 29, 2026 | Revolution Medicines Inc. | Open-market sale | −300 | $187.83 | $56,349 |
| Jun 29, 2026 | Revolution Medicines Inc. | Open-market sale | −100 | $188.57 | $18,857 |
| Jun 29, 2026 | Revolution Medicines Inc. | Open-market sale | −600 | $190.55 | $114,330 |
| Jun 29, 2026 | Revolution Medicines Inc. | Open-market sale | −541 | $191.87 | $103,802 |
| Jun 29, 2026 | Revolution Medicines Inc. | Open-market sale | −881 | $192.61 | $169,689 |
| Jun 18, 2026 | Revolution Medicines Inc. | Grant or award | +1,191 | — | — |
| May 18, 2026 | Replimune Group Inc. | Open-market sale | −37,324 | $5.08 | $189,606 |
| Apr 1, 2026 | Replimune Group Inc. | Grant or award | +251,240 | — | — |
| Dec 19, 2025 | Replimune Group Inc. | Grant or award | +200,000 | — | — |
Questions about Sushil Patel
What boards is Sushil Patel on?
Sushil Patel sits on the boards of Replimune Group Inc. and Revolution Medicines Inc.
What company is Sushil Patel the CEO of?
Sushil Patel is Chief Executive Officer of Replimune Group Inc.
How long has Sushil Patel served on boards?
Our records show at least 6 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.